Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease

Neurobiology of Aging

Volumn 35, Issue 4, 2014, Pages 935.e3-935.e8

  Li, Yuanzhe ^a   Sekine, Takeshi ^a   Funayama, Manabu ^a   Li, Lin ^a   Yoshino, Hiroyo ^a   Nishioka, Kenya ^a   Tomiyama, Hiroyuki ^a   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dementia; Gaucher disease; GBA; Parkinson's disease Parkinsonism

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; GLUCOSYLCERAMIDASE; LEVODOPA;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; EXON; FEMALE; GAUCHER DISEASE; GBA GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; HETEROZYGOSITY; HUMAN; JAPANESE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; VERY ELDERLY;

DEMENTIA; GAUCHER DISEASE; GBA; PARKINSON'S DISEASE/PARKINSONISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GAUCHER DISEASE; GENES, DOMINANT; GLUCOSYLCERAMIDASE; HETEROZYGOTE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; RISK FACTORS; YOUNG ADULT;

EID: 85058205837     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.09.019     Document Type: Article

References (25)

1. Aharon-Peretz J., Rosenbaum H., Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N.Engl. J. Med. 2004, 351:1972-1977.
2. Alcalay R.N., Caccappolo E., Mejia-Santana H., Tang M.X., Rosado L., Orbe Reilly M., Ruiz D., Ross B., Verbitsky M., Kisselev S., Louis E., Comella C., Colcher A., Jennings D., Nance M., Bressman S., Scott W.K., Tanner C., Mickel S., Andrews H., Waters C., Fahn S., Cote L., Frucht S., Ford B., Rezak M., Novak K., Friedman J.H., Pfeiffer R., Marsh L., Hiner B., Siderowf A., Payami H., Molho E., Factor S., Ottman R., Clark L.N., Marder K. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology 2012, 78:1434-1440.
3. Anheim M., Elbaz A., Lesage S., Durr A., Condroyer C., Viallet F., Pollak P., Bonaiti B., Bonaiti-Pellie C., Brice A. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 2012, 7:417-420.
4. Clark L.N., Kartsaklis L.A., Wolf Gilbert R., Dorado B., Ross B.M., Kisselev S., Verbitsky M., Mejia-Santana H., Cote L.J., Andrews H., Vonsattel J.P., Fahn S., Mayeux R., Honig L.S., Marder K. Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch. Neurol. 2009, 66:578-583.
5. Cullen V., Sardi S.P., Ng J., Xu Y.H., Sun Y., Tomlinson J.J., Kolodziej P., Kahn I., Saftig P., Woulfe J., Rochet J.C., Glicksman M.A., Cheng S.H., Grabowski G.A., Shihabuddin L.S., Schlossmacher M.G. Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing. Ann. Neurol. 2011, 69:940-953.
6. Duran R., Mencacci N.E., Angeli A.V., Shoai M., Deas E., Houlden H., Mehta A., Hughes D., Cox T.M., Deegan P., Schapira A.H., Lees A.J., Limousin P., Jarman P.R., Bhatia K.P., Wood N.W., Hardy J., Foltynie T. The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease. Mov. Disord. 2013, 28:232-236.
7. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
8. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., Kusel V.I., Collura R., Roberts J., Griffith A., Samii A., Scott W.K., Nutt J., Factor S.A., Payami H. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 2010, 4:781-785.
9. Hatano T., Kubo S., Sato S., Hattori N. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J.Neurochem. 2009, 111:1075-1093.
10. Hruska K.S., LaMarca M.E., Scott C.R., Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum. Mutat. 2008, 29:567-583.
11. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J.Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
12. Lesage S., Anheim M., Condroyer C., Pollak P., Durif F., Dupuits C., Viallet F., Lohmann E., Corvol J.C., Honore A., Rivaud S., Vidailhet M., Durr A., Brice A. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum. Mol. Genet. 2011, 20:202-210.
13. Mazzulli J.R., Xu Y.H., Sun Y., Knight A.L., McLean P.J., Caldwell G.A., Sidransky E., Grabowski G.A., Krainc D. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146:37-52.
14. Mitsui J., Mizuta I., Toyoda A., Ashida R., Takahashi Y., Goto J., Fukuda Y., Date H., Iwata A., Yamamoto M., Hattori N., Murata M., Toda T., Tsuji S. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch. Neurol. 2009, 66:571-576.
15. Nagayama H., Hamamoto M., Ueda M., Nagashima J., Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J.Neurol. Neurosurg. Psychiatry 2005, 76:249-251.
16. Nalls M.A., Duran R., Lopez G., Kurzawa-Akanbi M., McKeith I.G., Chinnery P.F., Morris C.M., Theuns J., Crosiers D., Cras P., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Mann D.M., Snowden J., Pickering-Brown S., Halliwell N., Davidson Y., Gibbons L., Harris J., Sheerin U.M., Bras J., Hardy J., Clark L., Marder K., Honig L.S., Berg D., Maetzler W., Brockmann K., Gasser T., Novellino F., Quattrone A., Annesi G., De Marco E.V., Rogaeva E., Masellis M., Black S.E., Bilbao J.M., Foroud T., Ghetti B., Nichols W.C., Pankratz N., Halliday G., Lesage S., Klebe S., Durr A., Duyckaerts C., Brice A., Giasson B.I., Trojanowski J.Q., Hurtig H.I., Tayebi N., Landazabal C., Knight M.A., Keller M., Singleton A.B., Wolfsberg T.G., Sidransky E. Amulticenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol. 2013, 70:727-735.
17. Nishioka K., Vilarino-Guell C., Cobb S.A., Kachergus J.M., Ross O.A., Wider C., Gibson R.A., Hentati F., Farrer M.J. Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa. Neurosci. Lett. 2010, 477:57-60.
18. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
19. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C.M., Clark L.N., Condroyer C., De Marco E.V., Durr A., Eblan M.J., Fahn S., Farrer M.J., Fung H.C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A.E., Lee-Chen G.J., Lesage S., Marder K., Mata I.F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L.V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E.K., Tayebi N., Toda T., Troiano A.R., Tsuji S., Wittstock M., Wolfsberg T.G., Wu Y.R., Zabetian C.P., Zhao Y., Ziegler S.G. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N.Engl. J. Med. 2009, 361:1651-1661.
20. Simon-Sanchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Kruger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
21. Tsuang D., Leverenz J.B., Lopez O.L., Hamilton R.L., Bennett D.A., Schneider J.A., Buchman A.S., Larson E.B., Crane P.K., Kaye J.A., Kramer P., Woltjer R., Kukull W., Nelson P.T., Jicha G.A., Neltner J.H., Galasko D., Masliah E., Trojanowski J.Q., Schellenberg G.D., Yearout D., Huston H., Fritts-Penniman A., Mata I.F., Wan J.Y., Edwards K.L., Montine T.J., Zabetian C.P. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 2012, 79:1944-1950.
22. Tsuji S., Choudary P.V., Martin B.M., Stubblefield B.K., Mayor J.A., Barranger J.A., Ginns E.I. Amutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N.Engl. J. Med. 1987, 316:570-575.
23. Weintraub D., Burn D.J. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov. Disord. 2011, 26:1022-1031.
24. Winder-Rhodes S.E., Evans J.R., Ban M., Mason S.L., Williams-Gray C.H., Foltynie T., Duran R., Mencacci N.E., Sawcer S.J., Barker R.A. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. Brain 2013, 136:392-399.
25. Yap T.L., Velayati A., Sidransky E., Lee J.C. Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity. Mol. Genet. Metab. 2013, 108:56-64.